Please use this identifier to cite or link to this item:
http://dr.iiserpune.ac.in:8080/xmlui/handle/123456789/6062
Title: | Recent Advances in Bioactive Artificial Ionophores |
Authors: | Roy, Arundhati TALUKDAR, PINAKI Dept. of Chemistry |
Keywords: | Anticancer agent Artificial ionophores Biological activity CFTR; Supramolecular chemistry 2021-JUL-WEEK1 TOC-JUL-2021 2021 |
Issue Date: | Oct-2021 |
Publisher: | Wiley |
Citation: | ChemBioChem, 22(20), 2925-2940. |
Abstract: | Several life-threatening diseases, also known as ‘Channelopathies’ are linked to irregularities in ion transport proteins. Significant research efforts have fostered the development of artificial transport systems that facilitates to restore the functions of impaired natural transport proteins. Indeed, a few of these artificial ionophores demonstrate the rare combination of transmembrane ion transport and important biological activity, offering early promises of suitability in ‘channel replacement therapy’. In this review, structural facets and functions of both cationophores and anionophores are discussed. Ionophores that are toxic to various bacteria and yeast, could be exploited as antimicrobial agent. Nevertheless, few non-toxic ionophores offer the likelihood of treating a wide range of genetic diseases caused by the gene mutations. In addition, their ability to disrupt cellular homeostasis and to alter lysosomal pH endow ionophores as promising candidates for cancer treatment. Overall, critically outlining the advances in artificial ionophores in terms of in vitro ion transport, possible modes of action and biological activities enables us to propose possible future roadmaps in this research area. |
URI: | http://dr.iiserpune.ac.in:8080/xmlui/handle/123456789/6062 https://doi.org/10.1002/cbic.202100112 |
ISSN: | 1439-4227 1439-7633 |
Appears in Collections: | JOURNAL ARTICLES |
Files in This Item:
There are no files associated with this item.
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.